Are the treatments safe, and what are the possible side effects
J Biol Chem 281:1742017431 Michelet F, Gueguen R, Leroy P, Wellman M, Nicolas A, Siest G (1995) Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits
There are three recommended injection sites for semaglutide : stomach, thigh, and upper arm
These findings also suggest that macrophage-derived insulin-like growth factor 1 (IGF-1) is a potential mediator of coronary arteriogenesis (187)
Additional considerations include: Dietary quality changes during weight loss programmes Increased urinary magnesium excretion in poorly controlled diabetes (though GLP-1 therapy typically improves glycaemic control) Concurrent medications that may affect magnesium status, such as proton pump inhibitors or diuretics It is important to note that routine magnesium monitoring is not currently recommended in NICE guidance (NG28) for patients on GLP-1 therapy
175,176 Tauroursodeoxycholic Acid (TUDCA) TUDCA, a bile acid derivative, similarly improves glucose homeostasis, enhances insulin sensitivity, and reduces hepatic steatosis in obese and diabetic mouse models
